MedTrace Logo

Vitamin D3 Supplementation and the T Cell Compartment in Multiple Sclerosis (MS)

NCT00940719 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2010-08-11

No results posted yet for this study

Summary

In patients with Relapsing Remitting Multiple Sclerosis (RRMS), the investigators observed a positive correlation between regulatory T cell (Treg) function and vitamin D status. The present goal is to assess whether Treg function improves on supplementation with vitamin D3.

Conditions

Interventions

DIETARY_SUPPLEMENT

vitamin D3

Oil-based solution, 1 dose of 500 microgram each day, during 3 months.

Sponsors & Collaborators

  • Orbis Medical Centre

    collaborator OTHER

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Raymond Hupperts, M.D., Ph.D. · Orbis Medical Center Sittard, Maastricht Univeristy Medical Center Maastricht

  • Joost Smolders, M.D. · Maastricht University Medical Center

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2010-03-31
Completion
2010-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00940719 on ClinicalTrials.gov